Release Summary

Class action securities litigation brought for American Renal Associates Holdings, Inc. (NYSE: ARA) investors pursuant to ARA’s false & misleading 4/21/16 IPO Registration Statement & Prospectus.

Lieff Cabraser Heimann & Bernstein, LLP